Pretargeting of human mammary carcinoma xenografts with bispecific anti-MUC1/anti-Ga chelate antibodies and immunoscintigraphy with PET
- 23 September 2001
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 28 (7) , 821-828
- https://doi.org/10.1016/s0969-8051(01)00246-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Pretargeted Peptide Imaging and TherapyCancer Biotherapy & Radiopharmaceuticals, 1999
- Pretargeting with the Affinity Enhancement System for RadioimmunotherapyCancer Biotherapy & Radiopharmaceuticals, 1999
- Two-step radio-immunotargeting of renal-cell carcinoma xenografts in nude mice with anti-renal-cell-carcinoma X anti-DTPA bispecific monoclonal antibodiesInternational Journal of Cancer, 1998
- Comparison of the biological properties of two anti-mucin-1 antibodies prepared for imaging and therapyCancer Immunology, Immunotherapy, 1997
- Characterization of a high-affinity monoclonal antibody specific for CD44v6 as candidate for immunotherapy of squamous cell carcinomasCancer Immunology, Immunotherapy, 1996
- The product of the human MUC1 gene when secreted by mouse cells transfected with the full-length cDNA lacks the cytoplasmic tailBiochemical and Biophysical Research Communications, 1992
- Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excessJournal of Immunological Methods, 1984